Natco Pharma (NATCOPHARM) Share Price near 52-week low: What the latest move means
- October 5, 2026
- Posted by: Chaitanya Auti
- Category: News
Natco Pharma Share Price is trading at Rs 785.80, down 1.87% from the previous close of Rs 800.75, and remains near its 52-week low while market capitalisation stands at Rs 15,708.15 crore. The latest Univest data confirms the price event but does not establish a company-specific catalyst. Still, Natco Pharma Share Price is attracting attention because the move places the stock close to a one-year low, with soft short-term momentum, a lower-than-sector valuation and a market cap that keeps it in the mid-cap healthcare bracket. For readers tracking Natco Pharma Share Price Today, the key question is not only where the stock is trading, but how the price action, technical backdrop and fundamentals fit together in current market conditions.
Natco Pharma Stock News is therefore about more than one red print on the screen. The stock is trading below its 50 DMA of Rs 826.78 and its 200 DMA of Rs 936.09, which keeps the near-term and longer-term trend under pressure. At the same time, the company’s P/E ratio of 13.73, P/B ratio of 1.68, ROE of 16.3%, ROCE of 17.16%, EPS of Rs 58.33 and book value of Rs 476.47 provide a useful fundamental anchor. The dividend yield of 0.62% also adds another layer to Natco Pharma Share Price analysis, even as the market continues to weigh price action against sector context and peer comparison.
Natco Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 785.8 |
| Previous Close | Rs 800.75 |
| Today's Move | Rs -14.95 (-1.87%) |
| Open | Rs 808.95 |
| High | Rs 808.95 |
| Low | Rs 784.75 |
| Market Capitalisation | Rs 15,708.15 crore |
Natco Pharma Ltd. (NATCOPHARM) traded at Rs 785.8 versus the previous close of Rs 800.75, a fall of 1.87%. The stock opened at Rs 808.95, reached a high of Rs 808.95, touched a low of Rs 784.75.
Natco Pharma Share Price Today shows a weak intraday setup with the stock opening at Rs 808.95, touching a high of Rs 808.95 and a low of Rs 784.75 before last trading at Rs 785.80. That leaves the share below the previous close of Rs 800.75 and down Rs 14.95 on the day. The move keeps Natco Pharma Share Price near its 52-week low and close to the lower end of the day’s range, which is why traders are watching the stock closely in Stock Market Today and Share Market Today conversations.
Because Natco Pharma Share Price is trading only a little above the day’s low, the price action reflects selling pressure rather than strong recovery attempts during the morning session. The company’s market capitalisation of Rs 15,708.15 crore keeps it firmly visible in healthcare market updates, but the near-one-year low setup means price discovery remains the focus. For anyone following Natco Pharma Share Price Live or Natco Pharma Share Price Update, the immediate attention shifts to whether the stock can stabilise around current support and improve its structure from here.
That makes technical analysis especially important for Natco Pharma Share Price today, because the chart is currently doing more of the talking than the headline move itself.
Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,708.15 crore |
| P/E Ratio | 13.73x |
| P/B Ratio | 1.68x |
| ROE | 16.3% |
| ROCE | 17.16% |
| EPS | Rs 58.33 |
| Book Value Per Share | Rs 476.47 |
| Dividend Yield | 0.62% |
Natco Pharma Ltd. (NATCOPHARM) fundamental metrics show P/E 13.73x, P/B 1.68x, ROE 16.3%, ROCE 17.16%. These figures provide context only and are not a buy or sell signal.
Natco Pharma Ltd. has a market capitalisation of Rs 15,708.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 13.73x, P/B at 1.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.3% and ROCE of 17.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 58.33, book value per share of Rs 476.47, dividend yield of 0.62%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.98x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 13.73x |
| Benchmark Median P/E | 26.98x |
| Benchmark Average P/E | 39.41x |
| Benchmark P/E Range | 0x to 616.89x |
| Company P/B Ratio | 1.68x |
| Benchmark Median P/B | 2.75x |
| Company ROE | 16.3% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 17.16% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 15,708.15 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Natco Pharma Ltd. (NATCOPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Natco Pharma Ltd. (NATCOPHARM) has a P/E ratio of 13.73x, which is below the benchmark median of 26.98x, a difference of -49.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Natco Pharma Ltd. (NATCOPHARM) has a ROE of 16.3%, which is above the benchmark median of 11.23%, a difference of +45.15%. Natco Pharma Ltd. (NATCOPHARM) has a ROCE of 17.16%, which is above the benchmark median of 13.17%, a difference of +30.3%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Life Sciences Ltd. | ALIVUS | 15,627.58 | 25.92 | 4.48 | 18.41 | 24.61 |
| Eris Lifesciences Ltd. | ERIS | 15,617.8 | 24.25 | 3.87 | 19.23 | 14.47 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 15,818.68 | 0 | 2.7 | -1.26 | 0.44 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 15,532.42 | 22.4 | 2.66 | 12.35 | 11.74 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 15,108.25 | 89.07 | 16.71 | 23.02 | 31.24 |
Natco Pharma Ltd. (NATCOPHARM) has a P/E ratio of 13.73x compared with the displayed peer median of 24.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.3% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 17.16% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Natco Pharma Ltd. (NATCOPHARM) has a market capitalisation of Rs 15,708.15 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Natco Pharma
- Natco Pharma Share Price is trading near its 52-week low, keeping the stock on near-term watchlists.
- Natco Pharma Share Price Today is below the 50 DMA and 200 DMA, which signals weak chart structure.
- Natco Pharma Fundamental Analysis shows P/E of 13.73 and P/B of 1.68, both below industry benchmarks.
- ROE of 16.3% and ROCE of 17.16% keep the business quality discussion active.
- Sector and peer comparison show Natco Pharma Share Price at a valuation discount versus several pharma names.
About Natco Pharma
Natco Pharma Share Price belongs to Natco Pharma Ltd., a healthcare company in the Pharmaceuticals & Drugs industry. The company operates within the Indian pharmaceutical space and is followed for its product and business profile within the sector. For readers tracking Natco Pharma Company News, the stock sits in a segment where earnings quality, product strategy and valuation can matter as much as short-term price action.
On the numbers supplied here, Natco Pharma Share Price is backed by a market capitalisation of Rs 15,708.15 crore, EPS of Rs 58.33 and book value of Rs 476.47. That combination helps frame the business as a meaningful listed pharma name rather than a small speculative counter. Natco Pharma Stock Performance is therefore usually assessed through both price action and fundamentals, especially when the share is moving near a yearly low. Univest readers often use the company overview, sector context and valuation view together when reviewing Natco Pharma Share Price Today.
Track Natco Pharma Share Price on Univest
Use Natco Pharma Ltd. (NATCOPHARM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Natco Pharma Share Price can be tracked on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern context, 52-week levels and market insights. Natco Pharma Share Price Today is best read alongside chart structure, sector comparison and valuation metrics so that the move is seen in context. Univest brings these elements together in one place for Natco Pharma Share Price, helping readers monitor the stock’s latest price action, stock news and broader market positioning without relying on fragmented updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Natco Pharma Share Price near a 52-week low?
Ans. Natco Pharma Share Price is near a 52-week low because it is trading at Rs 785.80, below the previous close of Rs 800.75 and under key moving averages. The latest Univest data does not establish a company-specific catalyst.
What is Natco Pharma Share Price Today?
Ans. Natco Pharma Share Price Today is Rs 785.80, down 1.87% from the previous close. The stock opened at Rs 808.95, touched Rs 808.95 and moved as low as Rs 784.75 during the morning session.
How does Natco Pharma Share Price look on valuation?
Ans. Natco Pharma Share Price looks relatively lower-valued versus its industry. The P/E is 13.73 and the P/B is 1.68, both below the same-industry benchmark median and average. That gives the stock a discounted valuation profile.
What do ROE and ROCE show for Natco Pharma Share Price?
Ans. Natco Pharma Share Price is supported by ROE of 16.3% and ROCE of 17.16%. Both sit above the industry median and average, which indicates respectable profitability and capital efficiency for the business.
What does EPS mean for Natco Pharma Share Price?
Ans. Natco Pharma Share Price has EPS of Rs 58.33. EPS shows earnings attributable to each share, so this figure helps investors assess the company’s profit generation alongside price and valuation metrics.
What does book value indicate for Natco Pharma Share Price?
Ans. Natco Pharma Share Price has book value of Rs 476.47. Book value per share shows the accounting net worth behind each share, which helps investors compare market price with underlying balance-sheet value.
What is the dividend yield for Natco Pharma Share Price?
Ans. Natco Pharma Share Price carries a dividend yield of 0.62%. Dividend yield is historical data and not a payout guarantee, but it adds another context point for income-oriented stock analysis.
How does Natco Pharma Share Price compare with pharma peers?
Ans. Natco Pharma Share Price trades at lower valuation multiples than peers such as Glenmark Life Sciences, Eris Lifesciences and Alembic Pharmaceuticals. It also carries a market cap broadly comparable with several listed pharma names.
Should investors track Natco Pharma Share Price on Univest?
Ans. Investors can track Natco Pharma Share Price on Univest for live price updates, technical indicators, fundamental ratios, 52-week levels and sector context. That helps place price action, valuation and peer comparison in one view.